top of page

Search


Biotech Scaling Operations: The Hidden Breakpoint CEOs Ignore
Biotech CEOs don’t fail because the science breaks. They fail because operations can’t scale. Here’s why operational discipline, not IP, determines who raises at Series B and beyond.

Attila Foris
Sep 30, 20252 min read


From Startup to Scale-Up: How to Overcome Biotech Scale-Up Challenges
👉 Scaling up is the critical inflection point for any biotech company. While achieving early success as a startup is a significant...

Attila Foris
Sep 24, 20257 min read
bottom of page
